2Principi N, Esposito S, Blasi F, et al. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community acquired lower respiratory tract infections[J]. Clin Infect Dis,2001,32(9) : 1281-1289.
3Waites KB ,Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen [J]. Clin Microbiol Rev, 2004,17(4) :697-728.
4Vervloet LA, Marguet C, Camargos PA. Infection by Mycoplasma pneumoniae and its importance as an etiological agent in childhood community-acquired pneumo- nias [J]. Braz J Infect Dis,2007,11(5):507-514.
5Chiang WC, Teoh OH, Chong CY, et al. Epidemiology, clinical characteristics and antimicrobial resistance patterns of community-acquired pneumonia in 1702 hospitalized children in Singapore [J]. Respirology,2007,12 (2) : 254-261.
6Korppi M, Heiskanen-Kosma T, Kleemola M. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae:serological results of a prospective,population-based study in primary health care [J ]. Respirology, 2004,9 ( 1 ) : 109-114.
7Ngeow YF, Suwanjutha S, Chantarojanasriri T, et al. An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia [J]. Int J Infect Dis,2005,9(3) : 144-153.
8Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children [J]. Pediatrics,2004,113 (4) :701-707.
9Toikka P, Juven T, Virkki R, et al. Streptococcus pneumoniae and Mycoplasma pneumoniae coinfection in community acquired pneumonia [J]. Arch Dis Child,2000, 83(5) :413-414.
10Heiskanen-Kosma T, Korppi M, Jokinen C, et al. Etiology of childhood pneumonia:serologic results of a prospective,population-based study [J]. Pediatr Infect Dis J, 1998,17(11) :986-991.
5Shah SS, Test M, Sheffler-Collins S, et al. Macrolide therapy and outcomes in a multicenter cohort of children hospitalized with Mycoplasma pneumoniae pneumonia[J]J Hosp Med, 2012 Jan 23. [Epub ahead of print].
6Narita M. Pathogenesis of neurologic manifestations of Mycoplasma Pneumoniae infection[J]Pediatr Neurol, 2009,41 (3) :159-166.
7Narita M. Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia[J]. Infect Chemother, 2010,16(3) : 162-169.
8Lu YJ,Chen TH, Lin LH, et al. Macrolide use shortens fever duration in Mycoplasma pneumoniae infection in children:a 2- year experience[J].J Microbiol Immunol Infect, 2008,41 (4) : 307-310.
9Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America[J]. Clin Infect Dis, 2011,53 (7): 25-76.
10Tagliabue C, Salvatore CM, Techasaensiri C, et al. The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection[J]. J Infect Dis, 2008,198(8) : 1180-1188.
